
Lars Prestegarden, MD
CEO,
Cytovation
Norway
MD, PhD in tumor biology, research at UCSF followed by Fulbright fellowship at Harvard/Brigham and Women's Hospital.
Co-founder and CEO of Cytovation.
Sessions
-
17-Oct-2023